CIN-107
CIN-107 is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function
Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects
Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects
Clinical Trials (7)
A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function
Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects
Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects
A Study of CIN-107 in Patients With Uncontrolled Hypertension
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7